Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 33: 319-327, 1987;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Catlin, D. H.
Right arrow Articles by Merdink, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Catlin, D. H.
Right arrow Articles by Merdink, J. L.

Clinical Chemistry, Vol 33, 319-327, Copyright © 1987 by American Association for Clinical Chemistry

Analytical chemistry at the Games of the XXIIIrd Olympiad in Los Angeles, 1984

DH Catlin, RC Kammerer, CK Hatton, MH Sekera and JL Merdink

The equipment, methods, logistics, and results of doping-control analyses for the 1984 Los Angeles Olympic Games are discussed in this article. Within 15 days, 1510 different urine specimens underwent 9440 screening analyses by a combination of gas chromatography, gas chromatography-mass spectrometry, "high-performance" liquid chromatography, and radioimmunoassay. These tests covered more than 200 different drugs and metabolites, including psychomotor stimulants, sympathomimetic amines, central nervous system stimulants, narcotic analgesics, and anabolic steroids. The results are summarized by class of drug. Less than 2% of the samples were found to contain a banned drug.


The following articles in journals at HighWire Press have cited this article:


Home page
J. Clin. Endocrinol. Metab.Home page
C. Wang, D. H. Catlin, B. Starcevic, D. Heber, C. Ambler, N. Berman, G. Lucas, A. Leung, K. Schramm, P. W. N. Lee, et al.
Low-Fat High-Fiber Diet Decreased Serum and Urine Androgens in Men
J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3550 - 3559.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. Aguilera, C. K. Hatton, and D. H. Catlin
Detection of Epitestosterone Doping by Isotope Ratio Mass Spectrometry
Clin. Chem., April 1, 2002; 48(4): 629 - 636.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Z. Leder, D. H. Catlin, C. Longcope, B. Ahrens, D. A. Schoenfeld, and J. S. Finkelstein
Metabolism of Orally Administered Androstenedione in Young Men
J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3654 - 3658.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. Aguilera, T. E. Chapman, B. Starcevic, C. K. Hatton, and D. H. Catlin
Performance Characteristics of a Carbon Isotope Ratio Method for Detecting Doping with Testosterone Based on Urine Diols: Controls and Athletes with Elevated Testosterone/Epitestosterone Ratios
Clin. Chem., February 1, 2001; 47(2): 292 - 300.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
D. H. Catlin, B. Z. Leder, B. Ahrens, B. Starcevic, C. K. Hatton, G. A. Green, and J. S. Finkelstein
Trace Contamination of Over-the-Counter Androstenedione and Positive Urine Test Results for a Nandrolone Metabolite
JAMA, November 22, 2000; 284(20): 2618 - 2621.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
H. G. Pope Jr, E. M. Kouri, and J. I. Hudson
Effects of Supraphysiologic Doses of Testosterone on Mood and Aggression in Normal Men: A Randomized Controlled Trial
Arch Gen Psychiatry, February 1, 2000; 57(2): 133 - 140.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
A. Strawford, T. Barbieri, M. Van Loan, E. Parks, D. Catlin, N. Barton, R. Neese, M. Christiansen, J. King, and M. K. Hellerstein
Resistance Exercise and Supraphysiologic Androgen Therapy in Eugonadal Men With HIV-Related Weight Loss: A Randomized Controlled Trial
JAMA, April 14, 1999; 281(14): 1282 - 1290.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
D. MacAuley
Fortnightly Review: Drugs in sport
BMJ, July 27, 1996; 313(7051): 211 - 215.
[Full Text]


Home page
JAMAHome page
D. H. Catlin and T. H. Murray
Performance-Enhancing Drugs, Fair Competition, and Olympic Sport
JAMA, July 17, 1996; 276(3): 231 - 237.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
H. G. Pope Jr and D. L. Katz
Psychiatric and Medical Effects of Anabolic-Androgenic Steroid Use: A Controlled Study of 160 Athletes
Arch Gen Psychiatry, May 1, 1994; 51(5): 375 - 382.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by the American Association for Clinical Chemistry.